This page contains a Flash digital edition of a book.
Spec Europe - Starna CRM:Layout 1 16/02/2011 17 News


A full range of Certified Reference Materials


Lifetime Guarantees ISO Guide 34 manufacturing ISO 17025 calibration Customised design capability


The world leader in UV, Visible and NIR certified reference materials


UK funding


£200m boost for academic research


Maria Burke


The UK government is to add £200m of new money to a fund that supports long-term university capital projects. The UK Research Partnership Investment Fund (UK RPIF), which was launched with a government investment of £100m in May 2012, was heavily oversubscribed. These new funds will more than double the number of projects that will benefit. To access the money, universities must match


From the Starna Spectroscopy Reference Laboratory


the funding by at least double the amount from private companies or charities. As well as supporting the best proposals already submitted by universities, the fund, which is managed by the Higher Education Funding Council, will now re-open for further bids. Universities can apply for between £10 and £35m per project. Applications are judged on value for money and must build on existing strong research capability. The fund will run for three years until 2015. An independent evaluation of previous government investment in research capital has shown how successful this type of funding can be in accelerating private sector investment in UK university research infrastructure, according to the Department of Business, Innovation and Skills (BIS). For example, a £4.3m investment


UK legislation Claims deadline clarified Karthryn Roberts


www.starna.com + 44 (0) 20 8501 5550


INSTRUMENT MANUFACTURERS PREFERRED SUPPLIER TO


In October, the UK Supreme Court dismissed an appeal by BCL against chemicals giant BASF to recover costs associated with inflated prices for certain vitamins, and so clarified the deadline for follow-on claims for damages. In 2001 the European Commission found


Registered No. FM 30093 NATIONAL


ACCREDITATION OF CERTIFICATION BODIES


REFERENCE MATERIALS 0659 4001


that BASF had been involved in the illegal price- fixing of vitamins, and imposed a fine of €296m. BASF appealed the amount of the fine but not the EC infringement decision. In March 2006, the European Court of First Instance (CFI) ruled in favour of BASF and reduced the fine to €237m. Under UK law it is possible for anyone that has suffered a loss as a result of cartel activity


10 Chemistry&Industry • November 2012


to bring a ‘follow-on action’ to the Competition Appeal Tribunal (CAT). Such actions must ‘follow-on’ from an infringement decision of the EU or UK competition authorities and allow the wronged party to claim damages from the infringers for the loss suffered. Importantly, any follow-on action must be brought to CAT within the two years following the expiry of the appeal period of the relevant decision. The case centred on what was the ‘relevant decision’ for the purpose of the two-year limitation period for bringing follow-on actions. The Supreme Court ruled that the claims should have been brought within two years of BASF’s deadline for appealing the Commission’s 2001 decision. BCL had made its claim over four years too late.


at Loughborough University led to a £60m investment by BAE Syst- ems; and at Dun- dee


Univer- sity,


an £8m invest- ment attracted £23m from AstraZeneca, Boehringer Ingelheim, GSK, Merck and Pfizer. The Research Councils UK welcomed the announcement, saying the extra money will ‘provide the vital tools to help the UK’s best scientists make new discoveries more quickly and drive future innovation’. The Russell Group of 24 leading universities


called the news ‘a very welcome shot in the arm for UK science and industry, especially following recent cuts to capital funding’.


Find C&I online at www.soci.org/chemistryandindustry


S


T


I


E


R


E


E


R


D


G


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64